SAN DIEGO, March 18, 2026 /PRNewswire/ — Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on innovative drug discovery and development in oncology, announced that they will present three posters from their ongoing Phase 2 clinical trial with spevatamig…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
